Insider trade

Officer purchased ~$1.3K of CVS shares in the open market

Traded Jan 23, 2025 · Filed Jan 27, 2026

CVS HealthCVS

~$1.3K
Reported value · 24 sh @ $53.70: 24
Holds after · shares reported: +58.3%
stock since the trade · S&P 500 +25.3%, $53.82 → $85.20 on Oct 1

Why it stands out

CVS Health's and President, Aetna spent $1.3K of their very own money to buy CVS Health shares.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jan 23, 2025
Reporting period: Not applicable
Filed with the SEC: Jan 27, 2026

OfficerIndirect holding<$25K

Context

Classification

open market purchase

Code P — open-market or private purchase

Absolute commitment

~$1,289

Shares × reported transaction price

Size band

<$25K

Rarity

Not enough history to judge

Confirmed open-market purchases by the same insider in the available history

Cluster activity

No other insider purchases within 30 days

Distinct insiders at the same issuer with confirmed open-market purchases

Size vs officer pay

This purchase equals less than 1% of the average reported total pay of the company's named executive officers other than the CEO, fiscal 2024 ($9.78M)

An average across the officers named in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-04-03. This person may not be one of them, so it is not their own pay. A size comparison, not a judgement

Timing vs results

78 days after results of Nov 6, 2024, 20 days before results of Feb 12, 2025

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on Jul 12, 2024 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.

Nixon v. CVS Health Corporation, docket 1:24-cv-05303, via CourtListener (court records). Nature of suit 850, company named as first defendant

After it was reported

After	Stock	S&P 500	Difference
7 days	+1.6%	-1.3%	+3.0%
30 days	+7.9%	-1.4%	+9.3%
90 days	+9.4%	+2.3%	+7.0%
180 days	+44.6%	+6.3%	+38.4%

Past results only. Not a forecast.

Source receipt

Record ID: 0000064803-26-000004
Filed / recorded: Jan 27, 2026, 10:20 PM UTC
Added to OQRO: Oct 2, 2026, 3:52 AM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: CVS HEALTH Corp
Issuer CIK: 64803
Ticker: CVS
Reporting person: Steven H Nelson
Relationship: Officer
Officer title: EVP and President, Aetna
Security: Common Stock (By Trust)
Table: Non-derivative (Table I)
Transaction date: Jan 23, 2025
Transaction code: P
Shares / units: 24
Price per share: $53.70
Acquired / disposed: Acquired (A)
Shares owned after: 24
Ownership form: Indirect — By Trust
Amendment: No

Footnotes from the filing

Shares purchased by a broker exercising discretion for a separately managed account in the name of a trust for the benefit of the Reporting Person that were not previously reported due to an error on the part of the broker. The shares were subsequently transferred to a trust for the benefit of the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these shares.